At a glance
- Originator Merck & Co
- Class Antivirals; Nucleosides; Small molecules
- Mechanism of Action Thymidine kinase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
Most Recent Events
- 30 Aug 1995 New profile
- 20 Mar 1995 No-Development-Reported for Herpes simplex virus infections in USA (Unknown route)
- 10 Oct 1994 Preclinical development for Herpes simplex virus infections in USA (Unknown route)